Get the Stockscreener App
2.72
0.00%
0.00
Bionexus Gene Lab Corp stock is traded at $2.72, with a volume of 331.92K.
It is up +0.00% in the last 24 hours and down -34.30% over the past month.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
See More
Previous Close:
$2.72
Open:
$2.8
24h Volume:
331.92K
Relative Volume:
3.05
Market Cap:
$6.56M
Revenue:
$9.26M
Net Income/Loss:
$-941.60K
P/E Ratio:
-37.78
EPS:
-0.072
Net Cash Flow:
$-2.65M
1W Performance:
-11.31%
1M Performance:
-34.30%
6M Performance:
-40.22%
1Y Performance:
-32.00%
1-Day Range:
$2.6001
$2.9594
1-Week Range:
$2.6001
$3.5194
52-Week Range:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
4.19 | 6.26B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
9.17 | 481.52M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.30 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.94 | 264.10M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
47.17 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market - marketscreener.com
Analyst Calls: Is BioNexus Gene Lab Corp a strong candidate for buy and hold2025 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Block Trades: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Outlook & Fast Entry Momentum Alerts - baoquankhu1.vn
BioNexus Gene Lab stockholders back governance and incentive plan - MSN
Whale Trades: Can BioNexus Gene Lab Corp be the next market leaderMarket Performance Summary & Entry Point Confirmation Signals - baoquankhu1.vn
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
Bearish Setup: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Summary & Consistent Return Investment Signals - baoquankhu1.vn
New Highs: Will QCR Holdings Inc stock recover after earningsDay Trade & Smart Swing Trading Alerts - baoquankhu1.vn
Why BioNexus Gene Lab Corp. stock is trending among retail tradersJuly 2025 Rallies & Precise Buy Zone Identification - Улправда
Insider Trends: Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - Улправда
How BioNexus Gene Lab Corp. stock reacts to job market dataJuly 2025 Intraday Action & Verified Stock Trade Ideas - Улправда
Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - ulpravda.ru
Why BioNexus Gene Lab Corp. stock is recommended by analystsJuly 2025 Chart Watch & AI Powered Market Entry Ideas - Улправда
Downgrade Watch: Can BioNexus Gene Lab Corp stock resist market sell offsShort Setup & Technical Pattern Alert System - moha.gov.vn
BioNexus Gene Lab Stockholders Back Governance and Incentive Plan - The Globe and Mail
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting - Investing.com Australia
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting By Investing.com - Investing.com South Africa
How supply chain issues affect BioNexus Gene Lab Corp. stockMarket Insider Reports & Capitalize On Fast Trends - bollywoodhelpline.com
BioNexus Gene Lab (NASDAQ:BGLC) Shares Down 0.2% – Should You Sell? - Defense World
BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN
BioNexus Chemrex leadership resignations prompt governance review - The Globe and Mail
Bionexus Gene Lab CorpMatthew L. Barsing appointed as chairman of Chemrex boardSEC filing - marketscreener.com
BioNexus Gene Lab Corp Evaluates CDMO Expansion - TradingView — Track All Markets
Inflation Data: Is BioNexus Gene Lab Corp. stock attractive after correctionQuarterly Portfolio Review & Daily Growth Stock Tips - DonanımHaber
What margin trends mean for BioNexus Gene Lab Corp. stockPortfolio Value Summary & Real-Time Volume Spike Alerts - DonanımHaber
Will BioNexus Gene Lab Corp. stock gain from lower inflation2025 Trade Ideas & Expert Approved Trade Ideas - DonanımHaber
Is BioNexus Gene Lab Corp. stock attractive after correction2025 Key Highlights & Growth Focused Entry Reports - DonanımHaber
Can BioNexus Gene Lab Corp. stock maintain growth trajectory2025 Market WrapUp & Stepwise Trade Execution Plans - Улправда
Bionexus Gene Lab completes investment in Fidelion Diagnostics - MSN
Analysis Recap: How BioNexus Gene Lab Corp stock valuations compare to rivalsStop Loss & Target Return Focused Stock Picks - moha.gov.vn
BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Nigeria
Is BioNexus Gene Lab Corp. stock safe for conservative investorsWeekly Profit Summary & Stepwise Trade Execution Plans - Newser
12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga
A Look at BioNexus Gene Lab Corp (BGLC) Shares in the Recent Past Indicates Growth - setenews.com
Blue Gold Sets $15 Million Gold Trading Facility - marketscreener.com
Bionexus Gene Lab completes strategic investment in Fidelion Diagnostics, secures 15% equity stake in global AI Oncologic platform - MarketScreener
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics - Investing.com
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics By Investing.com - Investing.com South Africa
BioNexus Gene Lab Corp. Completes Strategic Transaction with Fidelion Diagnostics, Securing Exclusive Rights for VitaGuard™ in Southeast Asia - Quiver Quantitative
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard - marketscreener.com
BioNexus Gene Lab (NASDAQ: BGLC) acquires 15% Fidelion stake, VitaGuard ASEAN rights - Stock Titan
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™ - The Manila Times
BioNexus Gene Lab secures $500 million equity purchase agreement By Investing.com - Investing.com Nigeria
BioNexus Gene Lab stock falls after securing $500M equity facility - Investing.com Nigeria
BioNexus Gene Lab stock falls after securing $500M equity facility By Investing.com - Investing.com South Africa
BioNexus Gene Lab Shares Jump After Securing $500 Million Equity Facility - MSN
Bionexus Gene Lab secures $500M equity facility from ARC Group - TipRanks
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.13%
4.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):